Showing 34,893 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Dating, relationships & feelings

How to Talk to Your Partner About Going on PrEP

Editor's pick
HIV Plus
1 February 2016
HIV & criminal law

Criminal laws on HIV transmission make little difference to sexual behaviour – or may make condomless sex more likely

News
1 February 2016
Undetectable viral load & treatment as prevention

HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later

Editor's pick
Swiss Medical Weekly
30 January 2016
HIV prevention policy

Where next for HIV prevention in New Zealand?

Editor's pick
BMJ Group blogs
30 January 2016
PrEP

We Aren’t the Sex Police: What PrEP Providers Say About Condoms & STIs

Editor's pick
BETA blog
30 January 2016
Infant feeding

For African women with HIV, not breastfeeding is not easy

Editor's pick
Reuters
29 January 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Hepatitis C transmission & prevention

HCV on the Rise in Dialysis Patients, CDC Warns

Editor's pick
MedPage Today HIV/AIDS
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Resistance

HIV resistance to favored treatment not uncommon

Editor's pick
Reuters
29 January 2016
PrEP programmes & uptake

London sexual health clinics step up their support for people buying PrEP online

News
29 January 2016
PrEP

Why don’t we give this HIV pill to those most at risk?

Editor's pick
Dazed
28 January 2016
Pharmaceutical industry

Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

Editor's pick
New York Times
28 January 2016

Январь, 2016 год.

January 2016
Cancer

US study shows importance of access to chemotherapy for HIV-positive patients with Hodgkin lymphoma

News
28 January 2016
The search for a cure

HIV protein manipulates hundreds of human genes to advance progression into AIDS, study shows

Editor's pick
UT Southwestern Medical Center
28 January 2016
The search for a cure

Study: HIV can hide and grow in 'sanctuaries' in body after it's undetectable in blood

Editor's pick
Washington Post
28 January 2016
Pharmaceutical industry

Massachusetts official challenges Gilead's hepatitis C drug prices

Editor's pick
Reuters
28 January 2016
The search for an HIV prevention vaccine

About that latest big Gates Foundation bet for HIV prevention

Editor's pick
Inside Philanthropy
27 January 2016
New & experimental HIV treatments

CytoDyn Announces HIV-Patients Approaching 17 Months of Complete Viral Suppression With PRO 140 Monotherapy

Editor's pick
Cytodyn Inc.
27 January 2016
Global health initiatives

PEPFAR's Dr Deborah Birx urges sharper focus to halt HIV globally

Editor's pick
Fogarty International Center
27 January 2016
Pharmaceutical industry

AHF Files Federal Lawsuit Against Gilead to Invalidate Patents on Key AIDS Drug

Editor's pick
AIDS Healthcare Foundation
27 January 2016
Contraception

The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

Editor's pick
RH Reality Check
27 January 2016